Proceedings of the National Academy of Sciences · 2005 · 90 citations · 49 references
Life SciencesInfectious DiseasesMicrobiologyHost-pathogen InteractionsInnate ImmunityMedical MicrobiologyBacterial InfectionsComplement RegulationComplement SystemHost Defense Against InfectionInnate Immune RecognitionInnate Immune ResponseComplement EvasionComplement In Infectious DiseaseComplement-mediated Bacterial KillingComplement-mediated DefenseComplement-mediated Host DefenseEvasion Of Complement-mediated KillingHost Defense Against Bacterial InfectionOuter Membrane Porins
Neisseria gonorrhoeae is the causative agent of gonorrhea, a disease that is restricted to humans. Complement forms a key arm of the innate immune system that combats gonococcal infections. N. gonorrhoeae uses its outer membrane porin (Por) molecules to bind the classical pathway of complement down-regulatory protein C4b-binding protein (C4bp) to evade killing by human complement. Strains of N. gonorrhoeae that resisted killing by human serum complement were killed by serum from rodent, lagomorph, and primate species, which cannot be readily infected experimentally with this organism and whose C4bp molecules did not bind to N. gonorrhoeae. In contrast, we found that Yersinia pestis, an organism that can infect virtually all mammals, bound species-specific C4bp and uniformly resisted serum complement-mediated killing by these species. Serum resistance of gonococci was restored in these sera by human C4bp. An exception was serotype Por1B-bearing gonococcal strains that previously had been used successfully in a chimpanzee model of gonorrhea that simulates human disease. Por1B gonococci bound chimpanzee C4bp and resisted killing by chimpanzee serum, providing insight into the host restriction of gonorrhea and addressing why Por1B strains, but not Por1A strains, have been successful in experimental chimpanzee infection. Our findings may lead to the development of better animal models for gonorrhea and may also have implications in the choice of complement sources to evaluate neisserial vaccine candidates.
49
Haider Raza, Annie John, Abderrahim Nemmar · Cellular Physiology and Biochemistry · 2013 · 47.3K citations · Full text
Global prevalence and incidence estimates of selected curable STDs.
Antonio Gerbase, Jane Rowley, David Heymann et al. · PubMed · 1998 · 530 citations
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +16